Role of lutein in preventing/slowing down age-related macular degeneration: A meta-analysis

Chinese Journal of Clinical Nutrition

Volumn 18, Issue 2, 2010, Pages 126-131

  Zhang, Fu Dong ^a   Wang, Li ^a   Cai, Mei Qin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Lutein zeaxanthin; Meta analysis

Indexed keywords

XANTHOPHYLL; ZEAXANTHIN;

ARTICLE; CLINICAL EVALUATION; COMPUTER PROGRAM; CONSULTATION; EXPERT SYSTEM; HUMAN; MEDICAL LITERATURE; QUALITY CONTROL; RETINA MACULA AGE RELATED DEGENERATION;

EID: 77953227645     PISSN: 1674635X     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1674-635X.2010.02.015     Document Type: Article

References (37)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness [J]. JAMA, 2004, 291(15): 1900-1901. (Pubitemid 38509505)
2. Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today [J]. JAMA, 2003, 290(15): 2057-2060. (Pubitemid 37430590)
3. Friedman DS, O'Colmain BJ, Tomany SC, et al. Prevalence of age-related macular degeneration in the United States [J]. Arch Ophthalmol, 2004, 122(4): 564-572. (Pubitemid 38456293)
4. Owen CG, Fletcher AE, Donoghue M, et al. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom [J]. Br J Ophthalmol, 2003, 87(3): 312-317. (Pubitemid 36307906)
5. Arroyo JG. A 76-year-old man with macular degeneration [J]. JAMA, 2006, 295(20): 2394-2406.
6. Totan Y, Yagci R, Bardak Y, et al. Oxidative macromolecular damage in age-related macular degeneration [J]. Curr Eye Res, 2009, 34(12): 1089-1093.
7. Cano M, Thimmalappula R, Fujihara M, et al. Cigarette smoking, oxidative stress, the anti-oxidant response through Nrf2 signaling, and age-related macular degeneration [J]. Vision Res, 2010, 50 (7): 652-664.
8. Janik-Papis K, Ulinska M, Krzyzanowska A, et al. Role of oxidative mechanisms in the pathogenesis of age-related macular degeneration [J]. Klin Oczna, 2009, 111(4-6): 168-173.
9. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration [J]. Science, 2005, 308(5720): 419-421. (Pubitemid 40530081)
10. Baird PN, Richardson, AJ, Robman LD, et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD) [J]. Human Mutation, 2006, 7(4): 337-342.
11. Zhao L, Sweet BV. Lutein and zeaxanthin for macular degeneration [J]. AJHP, 2008, 65(13): 1232-1238.
12. Bernstein PS. Nutritional interventions against age-related macular degeneration [J]. Acta Hortic, 2009, 841: 103-112.
13. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 [J]. Arch Ophthalmol, 2001, 119(10) : 1417-1436.
14. Bone GA, Landrum JT, Mayne ST, et al. Macular pigment in donor eyes with and without AMD: A case-control study [J]. Invest Ophthalmol Vis Sci, 2001, 42(3): 548.
15. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group [J]. JAMA, 1994, 272(18) : 1413-1420.
16. Snellen EL, Verbeek AL, VanDenHoogen GW, et al. Neovascular age-related macular degeneration and its relationship to antioxidant intake [J]. Acta ophthalmol Scand, 2002, 80(4): 368-371.
17. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22 [J]. Arch Ophthalmol, 2007, 125(9) : 1225-1232.
18. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey [J]. Am J Epidemiol, 2001, 153(5): 424-432. (Pubitemid 32185079)
19. Cho E, Hankinson SE, Rosner B, et al. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration [J]. Am J Clin Nutr, 2008, 87(6): 1837-1843. (Pubitemid 351872649)
20. van Leeuwen R, Boekhoom S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration [J]. JAMA, 2005, 294(24): 3101-3107. (Pubitemid 43016801)
21. Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative [J]. Arch Ophthalmol, 2006, 124(8): 1151-1162. (Pubitemid 44232345)
22. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study [J]. Ophthalmology, 2008, 115(2): 334-341. (Pubitemid 351175680)
23. Johnson EJ. Age-related macular degeneration and antioxidant vitamins: recent findings [J]. Curr Opin Clin Nutr Metab Care, 2010, 13(1): 28-33.
24. Zeimer M, Hense HW, Heimes B, et al. The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study [J]. Ophthalmology, 2009, 106(1): 29-36.
25. Bone RA, Landrum JT, Guerra LH, et al. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans [J]. J Nutr, 2003, 133(4): 992-998. (Pubitemid 36407115)
26. Khachik F, de Moura FF, Chew EY, et al. The efect of lutein and zeax-anxthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older [J]. Invest Ophthalmol Vis Sci, 2006, 47(12): 5234-5242. (Pubitemid 46723770)
27. Schalen W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (Lutein/Xanthophyl Eye Accumulation) study [J]. Arch Biochem Biophys, 2007, 458(2): 128-135.
28. Bernstein PS, Zhao DY, Wintch SW, et al. Resonance Raman measulement of macular carotenoids in normal subjects and in age-related macuular degeneration patients [J]. Ophthalmology, 2002, 109(10): 1780-1787.
29. Richer S, Stiles W, Statkute L, et al. Doublemasked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial) [J]. Optometry, 2004, 75(4): 216-230.
30. Evans JR, Henshaw K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration [J]. Cochrane Database Syst-Rev, 2008 (1): CD000253.
31. Rehak M, Fric E, Wiedemann P. Lutein and antioxidants in the prevention of age-related macular degeneration [J]. Ophthalmologe, 2008, 105(1): 37-38, 40-45.